drugset
drugset / Trial / NCT00434486

Study Evaluating Drug Interaction Between Multiple Doses of Ketoconazole and a Single Dose of SKI-606

NCT00434486 ↗

Phase 1 Completed 24 enrolled Wyeth is now a wholly owned subsidiary of Pfizer
RandomizedCrossoverOpen-labelTreatment

Summary

To investigate a potential pharmacokinetic interaction between SKI-606 and ketoconazole when co-administered.

Timeline

Start
2007-03
Primary completion
—
Completion
2007-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Bosutinib Small molecule — Oral

Indications

No indication recorded.